Drug induced interstitial lung disease
- PMID: 22896776
- PMCID: PMC3415629
- DOI: 10.2174/1874306401206010063
Drug induced interstitial lung disease
Abstract
With an increasing number of therapeutic drugs, the list of drugs that is responsible for severe pulmonary disease also grows. Many drugs have been associated with pulmonary complications of various types, including interstitial inflammation and fibrosis, bronchospasm, pulmonary edema, and pleural effusions. Drug-induced interstitial lung disease (DILD) can be caused by chemotherapeutic agents, antibiotics, antiarrhythmic drugs, and immunosuppressive agents. There are no distinct physiologic, radiographic or pathologic patterns of DILD, and the diagnosis is usually made when a patient with interstitial lung disease (ILD) is exposed to a medication known to result in lung disease. Other causes of ILD must be excluded. Treatment is avoidance of further exposure and systemic corticosteroids in patients with progressive or disabling disease.
Keywords: Lung; adverse drug reaction; diagnosis; drug-induced lung disease; mechanism of pulmonary toxicity; review.; treatment.
Figures


Similar articles
-
Analysis of 12 cases of antineoplastic agents-induced interstitial lung disease.Front Pharmacol. 2023 Aug 28;14:1218480. doi: 10.3389/fphar.2023.1218480. eCollection 2023. Front Pharmacol. 2023. PMID: 37701034 Free PMC article.
-
Drug-induced lung disease: a narrative review.J Bras Pneumol. 2024 Sep 27;50(4):e20240110. doi: 10.36416/1806-3756/e20240110. eCollection 2024. J Bras Pneumol. 2024. PMID: 39356911 Free PMC article. Review.
-
Characteristics of and risk factors for interstitial lung disease induced by chemotherapy for lung cancer.Ann Pharmacother. 2015 Apr;49(4):398-404. doi: 10.1177/1060028014566446. Epub 2015 Jan 6. Ann Pharmacother. 2015. PMID: 25565405
-
Current status of DILD in molecular targeted therapies.Int J Clin Oncol. 2012 Dec;17(6):534-41. doi: 10.1007/s10147-012-0494-5. Epub 2012 Nov 15. Int J Clin Oncol. 2012. PMID: 23152005 Review.
-
Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world.J Cancer Res Clin Oncol. 2022 Jul;148(7):1737-1746. doi: 10.1007/s00432-022-03932-3. Epub 2022 Feb 7. J Cancer Res Clin Oncol. 2022. PMID: 35129672 Free PMC article. Review.
Cited by
-
Interstitial lung disease following COVID-19 vaccination: a disproportionality analysis using the Global Scale Pharmacovigilance Database (VigiBase).BMJ Open Respir Res. 2023 Dec 11;10(1):e001992. doi: 10.1136/bmjresp-2023-001992. BMJ Open Respir Res. 2023. PMID: 38081769 Free PMC article.
-
Unrecognized Interstitial Lung Disease as a Result of Chronic Nitrofurantoin Use.Drug Saf Case Rep. 2016 Dec;3(1):13. doi: 10.1007/s40800-016-0037-5. Drug Saf Case Rep. 2016. PMID: 27778245 Free PMC article.
-
[Interstitial lung disease associated with lung cancer treatment].Zhongguo Fei Ai Za Zhi. 2013 May;16(5):267-72. doi: 10.3779/j.issn.1009-3419.2013.05.09. Zhongguo Fei Ai Za Zhi. 2013. PMID: 23676984 Free PMC article. Review. Chinese.
-
Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data.Nat Biotechnol. 2016 Jul 12;34(7):697-700. doi: 10.1038/nbt.3623. Nat Biotechnol. 2016. PMID: 27404875 No abstract available.
-
Recurrent bilateral lung infiltrates in a patient with ulcerative colitis.Breathe (Sheff). 2022 Dec;18(4):220210. doi: 10.1183/20734735.0210-2022. Epub 2023 Jan 10. Breathe (Sheff). 2022. PMID: 36865931 Free PMC article.
References
-
- Camus P, Rosenow E. Latrogenic lung disease. Clin Chest Med. 2004;25:xiii–xix. - PubMed
-
- Flieder D, Travis W. Pathologic characteristics of drug-induced lung disease. Clin Chest Med. 2004;25:37–45. - PubMed
-
- Nemery B, Bast A, Behr J, et al. Interstitial lung disease induced by exogenous agents: factors governing susceptibility. Eur Respir J . 2001;18:30S –42S. - PubMed
-
- Spear B, Heath-Chiozzi M, Huff J. Clinical application of pharmacogenetics. Trends Mol Med. 2002;7:201–4. - PubMed
-
- Lazarou J, Pomeranz B, Corey P. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–5. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources